Jeffrey Hung

Stock Analyst at Morgan Stanley

(0)
# 4693
Out of 5,358 analysts
260
Total ratings
36.94%
Success rate
-16.78%
Average return
42 Stocks
Name Action PT Current % Upside Ratings Updated
ACAD ACADIA Pharmaceutica...
Maintains: Equal-Weight
20 24
21.97 9.24% 25 May 20, 2025
CTNM Contineum Therapeuti...
Maintains: Overweight
25 20
4.77 319.29% 3 May 19, 2025
CGON CG Oncology
Maintains: Overweight
55 52
26.9 93.31% 3 May 19, 2025
RARE Ultragenyx Pharmaceu...
Maintains: Overweight
64 65
37.17 74.87% 8 May 9, 2025
JAZZ Jazz Pharmaceuticals
Maintains: Overweight
183 166
111.11 49.4% 6 May 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
15 17
8.6 97.67% 5 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
37 34
3.75 806.67% 3 Mar 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
72 72
68.09 5.74% 11 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
67 70
52.11 34.33% 11 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
185 150
125.42 19.6% 24 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
4 4
1.6 150% 3 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
85
49.95 70.17% 6 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
38 35
9.09 285.04% 6 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
27 27
11.91 126.7% 2 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Underweight
5
4.47 11.86% 2 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
70 67
32.32 107.3% 13 Feb 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
17 12
6.16 94.81% 4 Dec 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
92 95
n/a n/a 5 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
35
7.55 363.58% 1 Jul 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
50 70
33 112.12% 2 May 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
295 330
n/a n/a 3 Dec 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
10 4
1.02 292.16% 10 Dec 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
13 4
7.88 -49.24% 1 Dec 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Equal-Weight
1 4
0.98 308.16% 1 Dec 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Equal-Weight
60 140
4.97 2716.9% 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
14 14
2.15 551.16% 3 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
5 5
3.67 36.24% 1 Jul 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
9 3
1.22 145.9% 8 Mar 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
15 14
1.48 845.95% 7 Feb 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
42 21
n/a n/a 4 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
4 2
n/a n/a 3 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
50 10
2.06 385.44% 3 Jan 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
22 30
n/a n/a 6 Jan 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
23 22
43 -48.84% 10 Nov 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
2 2
n/a n/a 5 Sep 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
250 94
n/a n/a 8 Jul 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
146 149
17.01 773.02% 2 May 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
180
n/a n/a 12 Oct 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
100 60
1.79 3251.96% 5 Aug 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
7 6
3.53 69.97% 9 Apr 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
121 225
n/a n/a 9 Oct 6, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
58 54
0.48 11150% 6 May 8, 2020